124 related articles for article (PubMed ID: 27468100)
1. Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway.
Huang H; Wu K; Ma J; Du Y; Cao C; Nie Y
Int Immunopharmacol; 2016 Oct; 39():113-120. PubMed ID: 27468100
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EGF-induced migration and invasion by sulfated polysaccharide of Sepiella maindroni ink via the suppression of EGFR/Akt/p38 MAPK/MMP-2 signaling pathway in KB cells.
Jiang W; Tian W; Ijaz M; Wang F
Biomed Pharmacother; 2017 Nov; 95():95-102. PubMed ID: 28830011
[TBL] [Abstract][Full Text] [Related]
3. Cardiotoxin III suppresses MDA-MB-231 cell metastasis through the inhibition of EGF/EGFR-mediated signaling pathway.
Tsai PC; Hsieh CY; Chiu CC; Wang CK; Chang LS; Lin SR
Toxicon; 2012 Oct; 60(5):734-43. PubMed ID: 22683533
[TBL] [Abstract][Full Text] [Related]
4. Dopamine, by acting through its D2 receptor, inhibits insulin-like growth factor-I (IGF-I)-induced gastric cancer cell proliferation via up-regulation of Krüppel-like factor 4 through down-regulation of IGF-IR and AKT phosphorylation.
Ganguly S; Basu B; Shome S; Jadhav T; Roy S; Majumdar J; Dasgupta PS; Basu S
Am J Pathol; 2010 Dec; 177(6):2701-7. PubMed ID: 21075859
[TBL] [Abstract][Full Text] [Related]
5. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.
Zhou H; Wu J; Wang T; Zhang X; Liu D
Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388
[TBL] [Abstract][Full Text] [Related]
6. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
[TBL] [Abstract][Full Text] [Related]
7. P2X7 receptor stimulates breast cancer cell invasion and migration via the AKT pathway.
Xia J; Yu X; Tang L; Li G; He T
Oncol Rep; 2015 Jul; 34(1):103-10. PubMed ID: 25976617
[TBL] [Abstract][Full Text] [Related]
8. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling.
Chen HJ; Lin CM; Lee CY; Shih NC; Amagaya S; Lin YC; Yang JS
Int J Oncol; 2013 Aug; 43(2):629-37. PubMed ID: 23754208
[TBL] [Abstract][Full Text] [Related]
9. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.
Zuo JH; Zhu W; Li MY; Li XH; Yi H; Zeng GQ; Wan XX; He QY; Li JH; Qu JQ; Chen Y; Xiao ZQ
J Cell Biochem; 2011 Sep; 112(9):2508-17. PubMed ID: 21557297
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits oral squamous cell carcinoma proliferation and invasion via EGFR signaling pathways.
Zhen L; Fan D; Yi X; Cao X; Chen D; Wang L
Int J Clin Exp Pathol; 2014; 7(10):6438-46. PubMed ID: 25400722
[TBL] [Abstract][Full Text] [Related]
11. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of silibinin on EGFR signal-induced renal cell carcinoma progression via suppression of the EGFR/MMP-9 signaling pathway.
Liang L; Li L; Zeng J; Gao Y; Chen YL; Wang ZQ; Wang XY; Chang LS; He D
Oncol Rep; 2012 Sep; 28(3):999-1005. PubMed ID: 22736024
[TBL] [Abstract][Full Text] [Related]
13. IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway.
Yu XX; Hu Z; Shen X; Dong LY; Zhou WZ; Hu WH
Dig Dis Sci; 2015 May; 60(5):1265-72. PubMed ID: 25655003
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling.
Li Y; Fu LX; Zhu WL; Shi H; Chen LJ; Ye B
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):194-200. PubMed ID: 25921630
[TBL] [Abstract][Full Text] [Related]
15. Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Akt and MAPK pathways.
Chun J; Kim YS
Chem Biol Interact; 2013 Oct; 205(3):212-21. PubMed ID: 23867902
[TBL] [Abstract][Full Text] [Related]
16. EGFR and HER2 exert distinct roles on colon cancer cell functional properties and expression of matrix macromolecules.
Ellina MI; Bouris P; Aletras AJ; Theocharis AD; Kletsas D; Karamanos NK
Biochim Biophys Acta; 2014 Aug; 1840(8):2651-61. PubMed ID: 24792576
[TBL] [Abstract][Full Text] [Related]
17. CD24 associates with EGFR and supports EGF/EGFR signaling via RhoA in gastric cancer cells.
Deng W; Gu L; Li X; Zheng J; Zhang Y; Duan B; Cui J; Dong J; Du J
J Transl Med; 2016 Feb; 14():32. PubMed ID: 26830684
[TBL] [Abstract][Full Text] [Related]
18. PEA3 is necessary for optimal epidermal growth factor receptor-stimulated matrix metalloproteinase expression and invasion of ovarian tumor cells.
Cowden Dahl KD; Zeineldin R; Hudson LG
Mol Cancer Res; 2007 May; 5(5):413-21. PubMed ID: 17475671
[TBL] [Abstract][Full Text] [Related]
19. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
20. A novel epidermal growth factor receptor-signaling platform and its targeted translation in pancreatic cancer.
Gilmour AM; Abdulkhalek S; Cheng TS; Alghamdi F; Jayanth P; O'Shea LK; Geen O; Arvizu LA; Szewczuk MR
Cell Signal; 2013 Dec; 25(12):2587-603. PubMed ID: 23993964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]